{"id":740482,"date":"2023-03-15T16:38:48","date_gmt":"2023-03-15T20:38:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/"},"modified":"2023-03-15T16:38:48","modified_gmt":"2023-03-15T20:38:48","slug":"resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/","title":{"rendered":"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, March  15, 2023  (GLOBE NEWSWIRE) &#8212; ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. (Eastern Daylight Time) via webcast.<\/p>\n<p>More information about this event, including access to the live, audio-only webcast, may be accessed by visiting <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ylqHdySJQ-t30M3rYttmWdn4ssAvBS_Te5sP6zBXfsZimHysOSDd2-wUdx0J6IKZaPOkBSwlgkc3IVjZOM5mEwUPy1F4k05_lMqBZTHNZOk=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investor.resmed.com<\/a>. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.<\/p>\n<p>\n        <strong>About ResMed<\/strong><br \/>\n        <br \/>At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.\u00a0To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fgUTcE8BfZA_gdyhzBXfhdG-ACXE3GnvQVFwkWgGiyI1cWmeMYeZbgbp6t1jVLdHvvZiVbh4mo0HavJSVj1EJw==\" rel=\"nofollow noopener\" target=\"_blank\">ResMed.com<\/a> and follow @ResMed.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:41%;width:41%;min-width:41%;vertical-align: top\">\n            <strong>For investors<\/strong>\n          <\/td>\n<td style=\"max-width:59%;width:59%;min-width:59%;vertical-align: top\">\n            <strong>For media<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Amy Wakeham<\/td>\n<td style=\"vertical-align: top\">Jayme Rubenstein<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">+1 858.836.5000<\/td>\n<td style=\"vertical-align: top\">+1 858.836.6798<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <a href=\"mailto:investorrelations@resmed.com\" rel=\"nofollow noopener\" target=\"_blank\">investorrelations@resmed.com<\/a>\n          <\/td>\n<td style=\"vertical-align: top\">\n            <a href=\"mailto:news@resmed.com\" rel=\"nofollow noopener\" target=\"_blank\">news@resmed.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YmRmZmY3N2UtZDA2NS00NzkyLWE4ZGQtMTJkMTUzNWU4MGM4LTEwMTg3MDg=\/tiny\/ResMed-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) &#8212; ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. (Eastern Daylight Time) via webcast. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https:\/\/investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days. About ResMed At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740482","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) &#8212; ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. (Eastern Daylight Time) via webcast. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https:\/\/investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days. About ResMed At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live &hellip; Continue reading &quot;ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-15T20:38:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum\",\"datePublished\":\"2023-03-15T20:38:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/\"},\"wordCount\":225,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/\",\"name\":\"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=\",\"datePublished\":\"2023-03-15T20:38:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/","og_locale":"en_US","og_type":"article","og_title":"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum - Market Newsdesk","og_description":"SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) &#8212; ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. (Eastern Daylight Time) via webcast. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https:\/\/investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days. About ResMed At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live &hellip; Continue reading \"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-15T20:38:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum","datePublished":"2023-03-15T20:38:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/"},"wordCount":225,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/","name":"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=","datePublished":"2023-03-15T20:38:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI4NiM1NDY0NzMzIzIwMDcxMzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ResMed Announces Participation in the 2023 KeyBanc Life Sciences &amp; MedTech Investor Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740482"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740482\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}